Locati M, Zhou D, Luini W, Evangelista V, Mantovani A, Sozzani S
Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.
J Biol Chem. 1994 Feb 18;269(7):4746-53.
Monocyte Chemotactic Protein-1 (MCP-1), a member of the Cys-Cys branch of the chemokine superfamily, induced a mepacrine- and manoalide-sensitive increase in the release of [3H]arachidonic acid from prelabeled human monocytes and monocytic THP-1 leukemic cells. The effect was rapid (<30 s), reached maximum at optimal chemotactic concentrations, and was completely blocked by pretreatment of monocytes with Bordetella pertussis toxin. A specific antiserum and heat inactivation blocked the induction of arachidonic release by MCP-1. No [3H]arachidonic acid release was observed in the absence of Ca2+ influx (5 mM EGTA or 5 mM Ni2+) or in monocytes loaded with a Ca(2+)-buffering agent. However, using ionophore-permeabilized monocytes and controlled intracellular Ca2+ concentration it was possible to dissociate MCP-1-induced Ca2+ influx from [3H]arachidonic acid release. Thus, the MCP-1-induced increase in [Ca2+]i is necessary but not sufficient for arachidonic acid accumulation. Phospholipase A2 inhibitors (mepacrine, p-bromophenacyl bromide, and manoalide) blocked monocyte polarization and chemotaxis induced by MCP-1. The related Cys-Cys chemokines RANTES and LD78/MIP1 alpha also induced a rapid release of [3H]arachidonic acid, and their chemotactic activity was blocked by phospholipase A2 inhibitors. Brief (5 min) pretreatment of monocytes with platelet-activating factor amplified MCP-1-induced arachidonic acid release and, at MCP-1 suboptimal concentrations, synergized in inducing monocyte migration. Since MCP-1 and platelet-activating factor are induced concomitantly by inflammatory cytokines in monocytes and endothelial cells, we speculate that the observed synergism may have in vivo relevance. The results presented here show that the Cys-Cys chemokines MCP-1, LD78/MIP1 alpha, and RANTES cause rapid release of arachidonic acid in monocytes and that this may be important in inducing monocyte chemotaxis.
单核细胞趋化蛋白-1(MCP-1)是趋化因子超家族中Cys-Cys分支的成员,可诱导预先标记的人单核细胞和单核细胞性THP-1白血病细胞释放[3H]花生四烯酸,这种释放对米帕林和 manoalide敏感。该效应迅速(<30秒),在最佳趋化浓度时达到最大值,并且用百日咳博德特氏菌毒素预处理单核细胞可完全阻断该效应。特异性抗血清和热失活可阻断MCP-1诱导的花生四烯酸释放。在无Ca2+内流(5 mM EGTA或5 mM Ni2+)的情况下或在加载了Ca(2+)缓冲剂的单核细胞中未观察到[3H]花生四烯酸释放。然而,使用离子载体通透的单核细胞并控制细胞内Ca2+浓度,可以将MCP-1诱导的Ca2+内流与[3H]花生四烯酸释放分离。因此,MCP-1诱导的[Ca2+]i升高对于花生四烯酸积累是必要的,但并不充分。磷脂酶A2抑制剂(米帕林、对溴苯甲酰溴和manoalide)可阻断MCP-1诱导的单核细胞极化和趋化作用。相关的Cys-Cys趋化因子RANTES和LD78/MIP1α也可诱导[3H]花生四烯酸的快速释放,并且它们的趋化活性被磷脂酶A2抑制剂阻断。用血小板活化因子对单核细胞进行短暂(5分钟)预处理可增强MCP-1诱导的花生四烯酸释放,并且在MCP-1亚最佳浓度时,协同诱导单核细胞迁移。由于MCP-1和血小板活化因子在单核细胞和内皮细胞中由炎性细胞因子同时诱导产生,我们推测观察到的协同作用可能具有体内相关性。此处给出的结果表明,Cys-Cys趋化因子MCP-1、LD78/MIP1α和RANTES可导致单核细胞中花生四烯酸的快速释放,这可能在诱导单核细胞趋化中起重要作用。